Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
LaunchIBI Ag Secures $6.1 Million for Innovative Bioinsecticide Platform Development.
Feb 13, 2025
Ness ZionaBiotechnologyAgriculture and FarmingFarmingresearch
Product Description
IBI Ag has successfully closed the first tranche of its Series A funding round with a $6.1 million investment to advance its novel bioinsecticide platform that aims to provide effective crop protection solutions with a low ecological footprint.
Company Information
Company
IBI Ag
Location
Illinois Ave
Ness Ziona, Central District, Israel
About
IBI-Ag is an Israeli-based company addressing food protection challenges with novel biocontrol solutions. We use a novel biological active ingredient, combined with a new mode of action for developing a new class of bio-insecticides.
IBI-Ag's novel biological solution for insect control allowing precise pest control of any given insect with a safe mode of action and minimal environmental traces.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment IBI Ag ships something new, hires an exec or expands, usually minutes after it happens, and tells you who to reach.